Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.17NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.1.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.1.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.13.4.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.13.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.13.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.5.1.15NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.5.1.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.15NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JY.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JY.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.17NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DV.7.1.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DV.7.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.7.1.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DV.7.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DV.7.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.7.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JP.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JP.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JP.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCT.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCT.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCT.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.15NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.15NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GS.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GS.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.5.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.5.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.5.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FE.1.1.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FE.1.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FE.1.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.20NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used